Select Page

Re: Product Defect Alert for DBL-METRONIDAZOLE INTRAVENOUS INFUSION 500mg/100mL solution for injection bag

Home Forums Infexion Connexion FW: Product Defect Alert for DBL-METRONIDAZOLE INTRAVENOUS INFUSION 500mg/100mL solution for injection bag Re: Product Defect Alert for DBL-METRONIDAZOLE INTRAVENOUS INFUSION 500mg/100mL solution for injection bag

#74556
Michael Wishart
Participant

Author:
Michael Wishart

Position:

Organisation:

State:
NSW

It seems the attachment was omitted. Trying again.

Michael Wishart, CICP-E
Infection Control Coordinator

A 627 Rode Road, Chermside QLD 4032
P (07) 3326 3068 | F (07) 3607 2226 | E michael.wishart@svha.org.au | W http://www.hsnph.org.au
[cid:image001.png@01D01926.61F1C2B0] [cid:image004.jpg@01D3FD8B.1757FC40]
P Please consider the environment before printing this email

From: ACIPC Infexion Connexion [mailto:AICALIST@AICALIST.ORG.AU] On Behalf Of Michael Wishart
Sent: Wednesday, 6 June 2018 11:37 AM
To: AICALIST@AICALIST.ORG.AU
Subject: [ACIPC_Infexion_Connexion] FW: Product Defect Alert for DBL METRONIDAZOLE INTRAVENOUS INFUSION 500mg/100mL solution for injection bag

[Posted on behalf of Donna Cameron Moderator]

Dear Infexion Connexion subscribers,

I have just seen this product recall that will be of interest to many of you.

Regards,
Donna

Donna Cameron
Infection Control Consultant
T +61 (0) 3 8344 3574 (Monday, Wednesday & Friday); +61 (0) 3 9096 5233 (Tuesday & Thursday)
donna.cameron@unimelb.edu.au
Microbiological Diagnostic Unit Public Health Laboratory
The Peter Doherty Institute for Infection and Immunity
792 Elizabeth Street | Melbourne | Victoria | Australia | 3000
doherty.edu.au
[cid:image001.gif@01D3FD7C.B4C863C0]

From:

“Australian Society for Antimicrobials” <info@asainc.net.au>

To:

“ASA” <info@asainc.net.au>,

Date:

06/06/2018 09:12 AM

Subject:

Product Defect Alert for DBL??? METRONIDAZOLE INTRAVENOUS INFUSION 500mg/100mL solution for injection bag

PO Box 8266 Angelo Street
South Perth 6151 Western Australia
ABN: 31 081 739 370

Email: info@asainc.net.au
Twitter: @AusAntibiotics

Member Update 05 Jun 2018

Pfizer Australia has informed ASA of a Product Defect Alert for DBL METRONIDAZOLE INTRAVENOUS INFUSION 500mg/100mL solution for injection bag. See attached letter.

Please feel free to contact Wayne Lee if you wish to discuss this matter further:

Wayne Lee
Associate Medical Director
Pfizer Essential Health
Tel: +61 3 8744 5103
Mob: +61 401 100 383

Australian Society for Antimicrobials :: https://www.asainc.net.au
_________________________________________________________________________________

This email contains confidential information intended only for the person named above and may be subject to legal privilege. If you are not the intended recipient, any disclosure, copying or use of this information is prohibited. The Department provides no guarantee that this communication is free of virus or that it has not been intercepted or interfered with. If you have received this email in error or have any other concerns regarding its transmission, please notify Postmaster@dhhs.vic.gov.au
_________________________________________________________________________________

______________________________________________________________________
This email and any attachments to it (the “Email”) is confidential and is for the use only of the intended recipient, and may not be duplicated or used by any other party without the express consent of the sender. If you are not the intended recipient of the Email, please notify the sender immediately by return email, delete the Email, and do not copy, print, retransmit, store or act in reliance on the Email. St Vincent’s Health Australia (“SVHA”) does not guarantee that the Email is free from errors, viruses or interference. Emails to and from SVHA or its related entities may be scanned and filtered in locations outside Australia.

______________________________________________________________________
This email and any attachments to it (the “Email”) is confidential and is for the use only of the intended recipient, and may not be duplicated or used by any other party without the express consent of the sender. If you are not the intended recipient of the Email, please notify the sender immediately by return email, delete the Email, and do not copy, print, retransmit, store or act in reliance on the Email. St Vincent’s Health Australia (“SVHA”) does not guarantee that the Email is free from errors, viruses or interference. Emails to and from SVHA or its related entities may be scanned and filtered in locations outside Australia.

______________________________________________________________________
This email and any attachments to it (the “Email”) is confidential and is for the use only of the intended recipient, and may not be duplicated or used by any other party without the express consent of the sender. If you are not the intended recipient of the Email, please notify the sender immediately by return emhttps://clicktime.symantec.com/a/1/Eva1Wjr8W60tkRjJTww6P9XdgcyKXxwts8-UwT1JGjE=?d=ZGFIdlLcRB-hcrnuQelKJCtbDtKTBbu6pIehjApxoCkuIUdAAXDpEMh_Ar18gpCHNoFuyb6MeuG34OPtUmWBP11_gXInJ_xeakCxabTIRjl0XRmzRb1xVo5-IOl8dkBUk434vIgu52JbinhceH3s-hX_eLPBZW1e1bGZAiLXhhBLeP4iXsiLN1M0LXB_Arg5uVf7QGg2v7js2ckEYWchj0_Y4i5CDehLmcy7ERHhBRwU3gXaI_dWzafP-K2t6WUIqUaPt45ChoF03WQR8Tg8sT3HUpOWX_IbaLqrzBPiWorKwGyxzw0Q4X_uaUyLZ-PLDWLb-UV-gDXa_n-oOWiDojOg8RUfP2gPTwfww0isCwcbAEzw46lfcD0GslZqr0MECMZU1xeET0km1bwC30sCjrEYg8quEoEYJhDe0XkxfKX700qLEYP3r2IUpRiIPxzcK9KDzV7X9zxWnzZSsKlX9bNHCINPU9Vyl3ApSNf-YeV1vzsRGTk%3D&u=ail%2C%20delete%20the%20Email%2C%20and%20do%20not copy, print, retransmit, store or act in reliance on the Email. St Vincent’s Health Australia (“SVHA”) does not guarantee that the Email is free from errors, viruses or interference. Emails to and from SVHA or its related entities may be scanned and filtered in locations outside Australia.
MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.

The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.

Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au

To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.

You can unsubscribe from this list be sending ‘signoff aicalist’ (without the quotes) to listserv@aicalist.org.au

______________________________________________________________________
This email and any attachments to it (the “Email”) is confidential and is for the use only of the intended recipient, and may not be duplicated or used by any other party without the express consent of the sender. If you are not the intended recipient of the Email, please notify the sender immediately by return email, delete the Email, and do not copy, print, retransmit, store or act in reliance on the Email. St Vincent’s Health Australia (“SVHA”) does not guarantee that the Email is free from errors, viruses or interference. Emails to and from SVHA or its related entities may be scanned and filtered in locations outside Australia.

MESSAGES POSTED TO THIS LIST ARE SOLELY THE OPINION OF THE AUTHOR, AND DO NOT REPRESENT THE OPINION OF ACIPC.

The use of trade/product/commercial brand names through the list is discouraged by ACIPC. If you wish to discuss specific reference to products or services by brand or commercial names, please do this outside the list.

Archive of all messages are available at http://aicalist.org.au/archives – registration and login required.

Replies to this message will be directed back to the list. To create a new message send an email to aicalist@aicalist.org.au

To send a message to the list administrator send an email to aicalist-request@aicalist.org.au.

You can unsubscribe from this list be sending ‘signoff aicalist’ (without t